Effect of Metoclopramide on Renal Vascular Resistance Index and Renal Function in Patients Receiving a Low-Dose Infusion of Dopamine

Metocloprarnide is a dopamine receptor antagonist and, in large doses, has been shown to reverse the increase in renal blood flow, the diuresis and the natriuresis produced by a low-dose infusion of dopamine. We gave a single i. v. dose of metocloprarnide 10 mg to 21 patients on an intensive care unit who were haemodynamically stable and receiving dopamine 3 μg kg−1 min−1 Renal vascular resistance index, measured by duplex Doppler ultrasonography, did not change after metoclopramide. Renal function, measured by creatinine and osmolar clearance, natriuresis, kaliuresis and excretion fractions of sodium and potassium did not change after metoclopramide. We conclude that normal doses of metoclopramide (